| Literature DB >> 33919722 |
Laura Esquius1,2, Casimiro Javierre1, Inés Llaudó3, Inés Rama3, Guillermo R Oviedo4, Marta Massip-Salcedo2, Alicia Aguilar-Martínez2, Oscar Niño5, Núria Lloberas3.
Abstract
Physical exercise is known to have a dose-dependent effect on the immune system and can result in an inflammatory process in athletes that is proportional to the intensity and duration of exertion. This inflammatory process can be measured by cell markers such as dendritic cells (DCs), which, in humans, consist of the myeloid DC (mDCs) and plasmacytoid DC (pDCs) subpopulations. The aim of this study was to measure DC differentiation to determine the possible anti-inflammatory effects, after intense aerobic effort, of the intake of a 25 mL extra-virgin olive oil supplement. Three healthy sports-trained subjects went through resistance exercise loads on two days separated by a week: on one day after active supplement intake and on the other day after placebo supplement intake. The results show that the highest increase (77%) in the percentage of mDCs as a proportion of pDCs was immediately after testing. Independently of the supplement taken, mature mDCs showed a decreasing trend between the test one hour after and 24 h after testing ended. Nevertheless, measured in terms of the coefficient of variation, only the decrease (46%) for extra-virgin olive oil supplementation was statistically significant (95% CI: 30-62%; p = 0.05). In conclusion, an extra-virgin olive oil supplement could reduce the inflammatory impact of intense aerobic effort and improve recovery at 24 h.Entities:
Keywords: dendritic cells; inflammation; olive oil; physical exercise
Year: 2021 PMID: 33919722 PMCID: PMC8070678 DOI: 10.3390/ijerph18084128
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Supplement ingredients and nutritional content.
| Active Supplement | Placebo Supplement | |
|---|---|---|
| Ingredients | 100 mL commercial orange juice | 100 mL commercial orange juice |
| Energy (Kcal) | 277 | 52.8 |
| Fat (g) | 25 | 0.1 |
| Carbohydrates (g) | 12.6 | 12.6 |
Figure 1Protocol stages.
Figure 2Representative flow cytometry analysis of monocyte subsets in the peripheral blood of a volunteer after an exercise bout. (A). Monocytes gated in P1 in FCS-A/SSC-A. (B). Monocyte subsets in P1 assessed using a CD14 Per-CP/CD16-FITC dot plot.
Subject characteristics.
| Subject | #1 | #2 | #3 |
|---|---|---|---|
| Age (years) | 51 | 34 | 39 |
| Weight (kg) | 94 | 65 | 71 |
| Height (cm) | 181 | 165 | 178 |
| BMI (kg·m−2) | 28.75 | 23.90 | 22.39 |
Figure 3Analysis of mDC (red line) and plasmacytoid DC (pDC) (blue line) subtypes at different monitoring points (T0 to T4) according to the specific phenotypic markers Lin− HLADR+ CD11+/− CD123−/+. * Shows a strong maturation response observed for mDCs that mirrored by a decrease in pDCs.
Figure 4Molecule expression in monocytes analyzed at different monitoring points (T0 to T4), showing percentage of monocyte subsets before, during, and after testing. (A). CD14++CD16− (B). CD14++CD16+ (C). Pro-inflammatory CD14LowCD16+.
Figure 5Impact of olive oil supplement on mature dendritic cells (DCs) (mDC: red line; pDC: blue line) during and after intense exercise ((A). Non-treated group and (B). Treated group). The percentage of myeloid DCs (mDCs) increased in both treated and non-treated subjects from T2 to T3. The decrease in mDCs at T4 (24 h after the exercise) was greater for the treated subjects.
Coefficient of variation (∆T3-T4/∆T3-T2) evaluating recovery from exercise-induced inflammation in treated and non-treated subjects.
| Subjects | Non-Treated | Treated | ||||
|---|---|---|---|---|---|---|
| T2 | T3 | T4 | T2 | T3 | T4 | |
| #1 | 56.4 | 57.8 | 56 | 62.6 | 77.9 | 37.1 |
| CV1 | 1.29 | 2.63 | ||||
| #2 | 46.5 | 72.3 | 64.9 | 38 | 67.8 | 35.9 |
| CV2 | 0.29 | 1.1 | ||||
| #3 | 24.5 | 80.5 | 48.5 | 61.6 | 65.7 | 48.7 |
| CV3 | 0.57 | 4.15 | ||||
Metabolic data for treated and non-treated subjects.
| Treated | Non-Treated | |||||
|---|---|---|---|---|---|---|
| Subject | #1 | #2 | #3 | #1 | #2 | #3 |
|
| ||||||
| VE (L·min−1) | 154.1 | 78.8 | 152.4 | 146.5 | 93.5 | 132.9 |
| VO2/Kg (mL·kg·min−1) | 39.3 | 39.6 | 59 | 39.4 | 47.6 | 52.5 |
| QR | 1.127 | 1.064 | 1.13 | 1.121 | 1.016 | 1.087 |
| VCO2 (L·min−1) | 4.17 | 2.74 | 4.73 | 4.15 | 3.14 | 4.05 |
| FC (lat·min−1) | 159 | 177 | 173 | 152 | 183 | 171 |
| Metabolic rate (kcal·day−1) | 27,679 | 19,021 | 31,356 | 27,690 | 22,600 | 27,657 |
|
| ||||||
| 1M-45 | 4947 | 4924 | 5218 | 5072 | 4663 | 5058 |
| 1M-45-O2 | 275.6 | 268.7 | 392.4 | 279.5 | 294.3 | 360.3 |
| 1M-45-QR | 0.977 | 0.875 | 0.907 | 0.968 | 0.924 | 0.89 |
| %VO2 max | 77.1 | 74.2 | 77.1 | 79.9 | ||
| 64.01M-45-kcal | 641.3 | 429.8 | 726.8 | 666 | 445.5 | 645.8 |
| Kcal·metres | 0.130 | 0.087 | 0.139 | 0.131 | 0.096 | 0.128 |